![Alwyn Mwinga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alwyn Mwinga
Direttore/Membro del Consiglio presso Drugs for Neglected Diseases initiative
Posizioni attive di Alwyn Mwinga
Società | Posizione | Inizio | Fine |
---|---|---|---|
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Alwyn Mwinga
Formazione di Alwyn Mwinga
University of London | Graduate Degree |
University of Zambia | Graduate Degree |
Statistiche
Distribuzione geografica
Svizzera | 2 |
Regno Unito | 2 |
Zambia | 2 |
Posizioni
Graduate Degree | 2 |
Director/Board Member | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Alwyn Mwinga
- Esperienza